Topics
RioCan’s units fell recently in response to the bankruptcy of retailer Hudson’s Bay Company. However, it looks like the REIT will be able to release these stores to new tenants on comparable or better terms.


Meantime, RioCan continues to benefit from its focus on Canada’s biggest cities given their strong population growth (up 77% since 2017) and rising household income (up 45%)....

You Can See Our WSSF Income-Seeking Portfolio For June 2025 Here.


This month, we are updating our WSSF Portfolio for Income-Seeking Investors.


This portfolio is a good starting point for investors who need income....
QUAKER CHEMICAL CORP. $110 (www.quakerhoughton.com) remains a buy. The company makes specialty chemicals and lubricants for industrial uses. Quaker recently acquired two firms that make surface treatment chemicals for manufacturers: Japan’s Dipsol Chemicals Co., Ltd., purchased for $187.0 million, and U.K.-based Natech Ltd., for $6.5 million....
Since its spinoff from RTX in 2020, elevator maker Otis has seen its shares jump more than 115%. While tariffs are adding to RTX’s costs and hurting new orders, rising demand for maintenance and other services (which now supply over 60% of its revenue) should continue to push the stock higher.


OTIS WORLDWIDE CORP....
IDEXX LABORATORIES INC. $514 is a hold. The company (Nasdaq symbol IDXX; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 80.4 million; Market cap: $41.3 billion; Price-to-sales ratio: 10.9; No dividends paid; TSINetwork Rating: Average; www.idexx.com) makes equipment that veterinarians use to detect disease in animals.


In the first quarter of 2025, Idexx’s sales rose 3.6%, to $998.4 million from $964.1 million a year earlier....
BECTON DICKINSON & CO. $173 is a buy. The medical device maker (New York symbol BDX; Conservative Growth Portfolio, Manufacturing sector; Shares outstanding: 286.6 million; Market cap: $49.6 billion; Price-to-sales ratio: 2.4; Dividend yield: 2.4%; TSINetwork Rating: Above Average; www.bd.com) acquired the Critical Care product group of Edwards Lifesciences Corp....
PROCTER & GAMBLE CO. $167 is a buy. The consumer products giant (New York symbol PG; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 2.4 billion; Market cap: $400.8 billion; Price-to-sales ratio: 4.9; Dividend yield: 2.5%; TSINetwork Rating: Above Average; www.pg.com) now expects tariffs will cut its sales growth for the fiscal year ending June 30, 2025, to 2% from its earlier forecast for a 3% to 5% increase....
These two utilities continue to invest in new projects, particularly renewable power facilities, as they phase out their coal-fired plants. Those new assets should continue to drive their earnings and dividends. However, we still prefer Alliant due to its lower reliance on coal.


ALLIANT ENERGY CORP....
EMBECTA CORP. $11 is still a buy for long-term gains. The company (Nasdaq symbol EMBC; Conservative Growth Portfolio, Manufacturing sector; Shares outstanding: 58.4 million; Market cap: $642.4 million; Price-to-sales ratio: 0.6; Dividend yield: 5.5%; TSINetwork Rating: Average; www.embecta.com) makes insulin syringes, insulin pens and related products for the treatment of diabetes.


Embecta is also expanding beyond diabetes products....
Since their spinoff from the old General Electric (now operating as GE Aerospace), GE Vernova has soared 245%, while GE HealthCare is up 27%. We like the prospects for both, but prefer GE HealthCare for your new buying.


GE VERNOVA INC. $485 is a hold. The company (New York symbol GEV; Conservative Growth Portfolio, Manufacturing sector; Shares outstanding: 272.9 million; Market cap: $132.4 billion; Price-to-sales ratio: 3.7; Dividend yield: 0.2%; TSINetwork Rating: Average; www.gevernova.com) makes turbines and related equipment for gas-fired and nuclear power plants, plus equipment for wind farms....